Analyst picks & changes

Genentech Inc.

(GNE)

Barbara Hoffman of Piper Jaffray said a negative article last week in Barron's, stating that GNE's

Activase

tPA may face competition from angioplasty, is old news. The story, which

Read the full 331 word article

How to gain access

Continue reading with a
two-week free trial.